BLEND300 – 300 mg/mL Multi-Compound Blend – Research Use Only
BLEND300 is a sterile, oil-based research solution containing a combined concentration of 300 mg/mL of three active compounds formulated for laboratory research purposes.
This blend integrates a short-acting trenbolone ester, a short-acting drostanolone ester, and testosterone to allow researchers to evaluate multi-compound interaction, receptor binding dynamics, and comparative androgenic/anabolic activity in controlled experimental environments.
This product is supplied as a clear, colorless to pale yellow oil solution in a sealed multi-dose vial and is strictly intended for laboratory and research use only.
Compound Composition (Per mL)
-
Trenbolone Acetate: 100 mg
-
Drostanolone Propionate: 100 mg
-
Testosterone (Esterified): 100 mg
-
Total Combined Concentration: 300 mg/mL
(Specific testosterone ester may vary depending on batch.)
Key Product Information
Product Name: BLEND300
Active Compounds:
• Trenbolone Acetate
• Drostanolone Propionate
• Testosterone
Total Concentration: 300 mg/mL
Solution Type: Sterile oil-based solution
Appearance: Clear, colorless to pale yellow oil
Presentation: Multi-dose vial
Intended Use: Research use only
Research Applications
BLEND300 is used in laboratory studies including:
Multi-Compound Interaction Research
Evaluation of combined androgen receptor activity from multiple anabolic agents.
Short-Ester Pharmacokinetic Studies
Investigation of absorption and release profiles of acetate and propionate esters.
Comparative Androgenic/Anabolic Research
Analysis of receptor binding affinity and signaling differences between trenbolone, drostanolone, and testosterone.
Endocrine Feedback Modeling
Study of hormonal regulation patterns under combined androgen exposure.
Formulation Stability Studies
Research into compound compatibility and stability within multi-agent oil-based solutions.
All research must comply with institutional protocols and applicable regulations.
BLEND300 vs Single-Compound Research Products
| Feature | BLEND300 | Single-Ester Product |
|---|---|---|
| Composition | Triple-compound blend | Single compound |
| Total Concentration | 300 mg/mL | Varies |
| Ester Types | Acetate & Propionate (short esters) | Single ester |
| Research Focus | Synergistic interaction modeling | Isolated compound study |
| Solution Type | Sterile oil-based | Sterile oil-based |
| Appearance | Clear to pale yellow oil | Clear to pale yellow oil |
| Regulatory Status | Research use only | Research use only |
Research Summary
BLEND300 provides researchers with a combined androgen formulation designed to evaluate compound interaction and multi-pathway receptor activation within a single experimental model.
The inclusion of short-acting esters such as trenbolone acetate and drostanolone propionate allows for evaluation of relatively rapid pharmacokinetic behavior, while the addition of testosterone provides a baseline androgenic reference for comparative analysis.
This blend is suitable for laboratory studies focused on compound synergy, receptor affinity comparison, and multi-agent endocrine modeling.
Quality & Manufacturing
-
Manufactured under controlled laboratory conditions
-
Pharmaceutical-grade carrier oils utilized
-
Batch-tested for clarity and consistency
-
Securely sealed glass vial packaging
-
Documentation available for research compliance
Storage & Handling
-
Store at room temperature
-
Protect from excessive heat and direct light
-
Do not freeze
-
Handle using proper laboratory safety procedures
Reviews
There are no reviews yet.